Cryo-Cell International (CCEL) Stock Price, News & Analysis

Company Overview

Cryo-Cell International, Inc. is a pioneering provider of umbilical cord blood and tissue preservation services. Headquartered in Oldsmar, Florida, the company was founded in 1989 as the first private cord blood bank in the United States. Cryo-Cell operates FDA-registered and AABB-accredited laboratory facilities, maintaining stringent quality control measures and cryogenic storage systems to safeguard stem cell viability over long-term storage periods.

The company’s primary business activity centers on the collection, processing and secure storage of newborn stem cell sources harvested at birth. Trained medical personnel coordinate with healthcare providers to collect cord blood and cord tissue immediately after delivery. Samples are shipped in temperature-controlled containers to Cryo-Cell’s processing laboratories, where stem cell fractions are isolated, tested for purity and viability, and ultimately cryogenically stored in liquid nitrogen tanks.

Cryo-Cell serves families across the United States and in select international markets through a network of distribution partners. In addition to its core storage offerings, the company provides customized preservation plans, educational materials and dedicated client support to prospective parents. Cryo-Cell also collaborates with research institutions and participates in industry initiatives aimed at expanding the therapeutic applications of cord blood and tissue derivatives.

Guided by an experienced management team with expertise in biotechnology, clinical operations and regulatory affairs, Cryo-Cell International continues to invest in advanced processing technologies and service expansion. The company’s focus on safety, compliance and customer engagement positions it as a leading player in the evolving field of regenerative medicine and stem cell banking.

Key Stats

• Today's Range: $2.97 to $3.50
• 50-Day Range: $2.97 to $4.08
• 52-Week Range: $2.72 to $6.35
• Volume: 8,180 shs
• Average Volume: 7,880 shs
• Market Capitalization: $27.16 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Hold

Cryo-Cell International Stock Analysis - MarketRank™

Cryo-Cell International scored higher than 5% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.0 / 5
• Analyst Rating: Hold

Consensus Rating

Cryo-Cell International has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Cryo-Cell International has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Cryo-Cell International is -10.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Cryo-Cell International is -10.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.20% of the float of Cryo-Cell International has been sold short.

Short Interest Ratio / Days to Cover

Cryo-Cell International has a short interest ratio ("days to cover") of 1.33, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Cryo-Cell International has recently increased by 40.17%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Cryo-Cell International does not currently pay a dividend.

Dividend Growth

Cryo-Cell International does not have a long track record of dividend growth.

News and Social Media

• Score: N/A
• News Sentiment: N/A

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Cryo-Cell International insiders have not sold or bought any company stock.

Percentage Held by Insiders

38.59% of the stock of Cryo-Cell International is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

10.44% of the stock of Cryo-Cell International is held by institutions.

Company Calendar

• Last Earnings: 4/14/2026
• Today: 5/31/2026
• Fiscal Year End: 11/30/2026

Industry, Sector and Symbol

• Stock Exchange: NYSEAMERICAN
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Healthcare
• Current Symbol: NYSEAMERICAN:CCEL
• CIK: 862692
• Web: www.cryo-cell.com
• Phone: (813) 749-2100
• Fax: 813-855-4745
• Employees: 90
• Year Founded: 1989

Profitability

• EPS (Trailing Twelve Months): ($1.06)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$2.43 million
• Net Margins: -8.52%
• Pretax Margin: -8.95%
• Return on Equity: N/A
• Return on Assets: -4.26%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.62
• Quick Ratio: 0.60

Sales & Book Value

• Annual Sales: $31.57 million
• Price / Sales: 0.86
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($2.31) per share
• Price / Book: -1.46

Miscellaneous

• Outstanding Shares: 8,060,000
• Free Float: 4,947,000
• Market Cap: $27.16 million
• Optionable: Not Optionable
• Beta: 0.49